Risk factor
High price volatility
Profitability factor
Favourable analyst view
About
Implantica AG, a medtech company, researches, develops, and sells medical implants for unmet medical needs in Switzerland. Its lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. The company also develops e-InVivo, a sensor implant to monitor a multitude of health parameters and provide diagnostic information, as well as...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of IMP-A-SDB.ST is 70 and suggests 40% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell